Product Reports Resources Pricing Login Book a demo

Proscia

Biotech & Life Sciences · Philadelphia, United States · Founded 2014

Developer of pathology cloud technology for use in medicine MoreLess

A software company that develops and commercializes a digital pathology platform, Concentriq, to accelerate pathology's transformation toward a data-driven discipline. The platform is designed for image and workflow management in laboratory settings, with a focus on cancer diagnosis and research.

The business model is based on providing software as a service (SaaS) to clinical and research laboratories. The company's target clients include anatomic pathology laboratories, contract research organizations (CROs), and pharmaceutical and biotechnology companies. Proscia operates in the digital pathology market, which is a segment of the broader healthcare technology industry.

The company generates revenue through subscriptions to its Concentriq platform and its AI-powered applications. These applications are designed to improve the efficiency and accuracy of pathology workflows, ultimately aiming to enhance patient outcomes in areas like oncology.

Keywords: digital pathology, cancer diagnosis, AI, workflow management, precision medicine, SaaS, healthcare technology, oncology, image analysis, laboratory automation

Valuation $100–500M
Revenue $10–50M
Headcount 100–500
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Proscia and the history behind them.

Talent graph

Proscia's talent

Book a demo to see the people
Employees mapped 127 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 13 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

17 investors on Proscia's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage
Emerald Development Managers
TCP Venture Capital
Robin Hood Ventures
A-Level Capital
Series A 5 investors entered at this stage
Flybridge Capital Partners
Fusion Fund
Razor's Edge Ventures
Scale Venture Partners
Hitachi
Series B+ 8 investors entered at this stage
Triangle Peak Partners
Alpha Intelligence Capital
ROBO Global Ventures
Hitachi Ventures
Highline Capital Management
Insight Partners
Avenue Capital Group
Interwoven Ventures

Global footprint

Where Proscia has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States76.2%
🇨🇦 Canada6.9%
🇬🇧 United Kingdom5%
🇮🇪 Ireland4%
🇳🇱 Netherlands3%
Top 5 of 9 shown
Web traffic by country
27K monthly visits
across markets
🇺🇸 United States74.4%
🇨🇦 Canada8.9%
🇮🇳 India4.1%
🇦🇺 Australia3.3%
🇯🇵 Japan2.6%
Top 5 markets shown

Market sentiment

What the market is saying about Proscia

An AI-synthesized read of the highest-engagement posts about Proscia on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Proscia on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.